Enfusion, Inc.

NYSE:ENFN Stock Report

Market Cap: US$1.4b

Enfusion Future Growth

Future criteria checks 5/6

Enfusion is forecast to grow earnings and revenue by 74.8% and 16.3% per annum respectively. EPS is expected to grow by 68.1% per annum. Return on equity is forecast to be 27.3% in 3 years.

Key information

74.8%

Earnings growth rate

68.1%

EPS growth rate

Software earnings growth16.7%
Revenue growth rate16.3%
Future return on equity27.3%
Analyst coverage

Good

Last updated14 Jan 2025

Recent future growth updates

Recent updates

An Update On The Enfusion Buyout

Jan 29

Enfusion: Revenue Growth Should Start To Accelerate

Dec 24

Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?

Nov 23
Is There An Opportunity With Enfusion, Inc.'s (NYSE:ENFN) 32% Undervaluation?

Why Private Equity Will Buyout Enfusion

Oct 29

Enfusion: Growth Should Accelerate In Coming Quarters

Aug 19

Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality

Aug 14
Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality

Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating

Jun 16

Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?

Mar 13
Is Now An Opportune Moment To Examine Enfusion, Inc. (NYSE:ENFN)?

Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal

Feb 19
Capital Allocation Trends At Enfusion (NYSE:ENFN) Aren't Ideal

Enfusion: Product Is Sticky And Industry Is Huge

Jan 18

Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Jan 04
Calculating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%

Dec 02
Investors Appear Satisfied With Enfusion, Inc.'s (NYSE:ENFN) Prospects As Shares Rocket 28%

Enfusion: Still Bullish Considering Q3 EBITDA Beat

Nov 08

Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching

Oct 31
Why Enfusion, Inc. (NYSE:ENFN) Could Be Worth Watching

Enfusion Faces Cross-Currents In Investment Management Software Market

Aug 24

Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 11
Enfusion, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Enfusion: Multiple Catalysts

Jun 20

Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 08
Enfusion, Inc.'s (NYSE:ENFN) Intrinsic Value Is Potentially 32% Above Its Share Price

Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Feb 08
Here's Why We're Not At All Concerned With Enfusion's (NYSE:ENFN) Cash Burn Situation

Enfusion brings on Shift4 Payments' Brad Herring as CFO

Dec 19

Earnings and Revenue Growth Forecasts

NYSE:ENFN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262793950648
12/31/20252382534479
12/31/20242031323358
9/30/202419532132N/A
6/30/202418831728N/A
3/31/202418221626N/A
12/31/202317561626N/A
9/30/202316961727N/A
6/30/202316361522N/A
3/31/202315731219N/A
12/31/2022150-9614N/A
9/30/2022142-208-71N/A
6/30/2022132-207-18-9N/A
3/31/2022121-200-14-5N/A
12/31/2021112-188-80N/A
9/30/2021103-1-13-5N/A
6/30/2021932-33N/A
3/31/2021853-7-1N/A
12/31/2020804-32N/A
12/31/20195913812N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ENFN's forecast earnings growth (74.8% per year) is above the savings rate (2.6%).

Earnings vs Market: ENFN's earnings (74.8% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: ENFN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ENFN's revenue (16.3% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: ENFN's revenue (16.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ENFN's Return on Equity is forecast to be high in 3 years time (27.3%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 11:01
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Enfusion, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Koji IkedaBofA Global Research
Kevin McVeighCredit Suisse
Parth TalsaniaEquisights